BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gento-Caro Á, Vilches-Herrando E, García-Morales V, Portillo F, Rodríguez-Bey G, González-Forero D, Moreno-López B. Interfering with lysophosphatidic acid receptor edg2/lpa1 signalling slows down disease progression in SOD1-G93A transgenic mice. Neuropathol Appl Neurobiol 2021. [PMID: 33508894 DOI: 10.1111/nan.12699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun K, Chen RX, Li JZ, Luo ZX. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Hereditas 2022;159:16. [PMID: 35241179 DOI: 10.1186/s41065-022-00229-w] [Reference Citation Analysis]
2 García-Morales V, Gento-Caro Á, Portillo F, Montero F, González-Forero D, Moreno-López B. Lysophosphatidic Acid and Several Neurotransmitters Converge on Rho-Kinase 2 Signaling to Manage Motoneuron Excitability. Front Mol Neurosci 2021;14:788039. [PMID: 34938160 DOI: 10.3389/fnmol.2021.788039] [Reference Citation Analysis]
3 Gento-Caro Á, Vilches-Herrando E, Portillo F, González-Forero D, Moreno-López B. Targeting autotaxin impacts disease advance in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Brain Pathol 2021;:e13022. [PMID: 34585475 DOI: 10.1111/bpa.13022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Gallardo FS, Córdova-Casanova A, Brandan E. The linkage between inflammation and fibrosis in muscular dystrophies: The axis autotaxin-lysophosphatidic acid as a new therapeutic target? J Cell Commun Signal 2021;15:317-34. [PMID: 33689121 DOI: 10.1007/s12079-021-00610-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]